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Abstract
Title: Effect of Intravenous Ondansetron on Blood Pressure when Administered Prior
to the Establishment of Subarachnoid Anesthesia.
Background: Hypotension is a known effect of spinal anesthesia. In recent years, ondansetron
has been explored as another means of attenuating spinal-anesthesia induced hypotension (SIH).
Purpose: This case study looks at one clinical application of this intervention and examines the
literature on the topic to determine the usefulness of administering IV ondansetron prior to spinal
anesthesia.
Process: In the clinical setting, IV ondansetron was given prior to administering spinal
anesthesia; this case is discussed in detail. The databases CINAHL and PubMed were searched
to attain 13 randomized controlled trials which studied this intervention. These studies were
reviewed and recommendations were made based on the literature.
Results: More uniform research should be done on this topic. However, it can be recommended
to administer 4 mg ondansetron intravenously about 5 minutes before establishing spinal
anesthesia. Existing methods of preventing and treating SIH should still be employed when
necessary.
Implications: IV ondansetron can be used as an additional tool to help prevent spinal-induced
hypotension, potentially minimizing adverse outcomes associated with hypotension resulting
from spinal anesthesia.
Keywords: Ondansetron, hypotension, spinal anesthesia, spinal-induced hypotension
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Background
Spinal anesthesia is the administration of local anesthetic agents, and other adjunct
medications into the subarachnoid space with the purpose of blocking sensory and motor
transmission at the roots of spinal nerves. It was first successfully used in 1898 on a patient
having surgical resection of a tuberculous ankle joint who had previous adverse reactions to
general anesthesia. Fifteen milligrams (mg) of cocaine was administered intrathecally. The
patient was pain free during surgery and had minimal adverse effects post-operatively including
nausea and headache (Wulf, 1998). Today, spinal anesthesia is commonly used for various
procedures involving the lower extremities, perineum, and abdomen (Nagelhout, 2014).
Hypotension is a known side-effect of spinal anesthesia. Tubog, Kane, and Pugh (2017),
cite the incidence of spinal anesthesia-induced hypotension (SIH) at 15-33%. Some sources
indicate an even higher (as high as 80%) prevalence (Wang et al., 2014). The variable prevalence
rate can be owed to individual patient factors, including comorbidities and anesthetic technique.
Many sources indicate that the incidence of hypotension is greater in the obstetric population
than in other patient populations. Hypotension has negative implications on every population as
it can result in decreased perfusion and oxygen delivery to vital organs. Further implications
exist in the obstetric population, “hypotension during spinal anesthesia for cesarean delivery
remains a common clinical problem that is associated with morbidity for both mother (nausea
and vomiting) and fetus (fetal acidosis)” (Ngan Kee, Khaw, & Ng, 2005, p. 744).
Often, the current preventative treatments are not sufficient, requiring pharmacological
intervention which becomes a reactive strategy rather than proactive. Recently, a new measure,
the administration of intravenous ondansetron prior to administering the spinal anesthetic, has
come into question as a viable preventive strategy to mitigate SIH. If this proves to be true, it
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could improve the safety of spinal anesthesia by decreasing the incidence of hypotension and its
negative effects.
Case Report
A 64-year-old, 5’2”, 72.5 kg female, presented for a total knee arthroplasty. She had
osteoarthritis of both knees requiring replacement, however, only the left knee was to be
replaced. Her past medical history included asthma, GERD, and hypertension. She had a past
surgical history of rotator cuff repair, tubal ligation, and knee arthroscopy. Her home
medications included albuterol, Celebrex 200 mg, gabapentin 100 mg, hydrochlorothiazide 25
mg, and omeprazole 20 mg. She had no known drug allergies and was classified as an ASA 2.
Pre-anesthetic evaluation did not reveal any abnormal labs or studies. Physically, she presented
with knee pain. Her airway evaluation was unremarkable. Baseline vital signs were as follows:
BP 138/84, HR 74, RR 16, SpO2 95%, and temperature 98.9 degrees Fahrenheit. In the
preoperative holding room, an 18-gauge IV was started in her left hand and she was given 2 mg
midazolam.
The patient was brought to the OR at 0631, was given 4 mg ondansetron intravenously,
and was given a bolus of 500 mL lactated ringers, while being attached to standard monitoring.
Initial BP while supine was 135/85 (101) with a HR of 79. Additionally, 6 mg of midazolam
(now a total of 8 mg) was administered prior to the block per the anesthesiologist’s request. She
was positioned in a sitting position on the OR table and a spinal block was administered at 0645.
The following medications were administered intrathecally: 1.6 ml of bupivacaine 0.75% (12
mg) and 25 mcg of fentanyl. After the block, she was immediately placed in a supine position
and a propofol infusion was started at a rate of 12.5 mcg/kg/min. Oxygen was also applied via
nasal cannula at three liters per minute. Additionally, one gram of Ancef and one gram of
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tranexamic acid were administered during this time. The first BP after the block was established
was 109/68 (88). Ten minutes after the block was established the BP dropped to 101/60 (73) and
100 mcg of phenylephrine was administered. This was the only dose of vasopressor given. The
tourniquet was inflated at 0708 and incision was made 0710. Systolic blood pressures after the
block ranged from 98 to 120, and diastolic blood pressures ranged from 53-68. The lowest MAP
that was encountered was 68 and occurred 85 minutes after the block was administered. Heart
rate throughout the case ranged from 58-80 BPM. The tourniquet was let down at 0801 and a
second gram of tranexamic acid was given. The propofol infusion was discontinued at 0813. A
total of 1,200 mL LR was given throughout the case and 225 mL was determined to be the
estimated blood loss. The patient was transferred to the PACU at 0831 with the following vital
signs: BP 108/64, HR 61, SpO2 100%, RR 14. It was realized that the surgeon forgot to apply
the subcutaneous layer of sutures and he decided to do this at the bedside in the PACU. To
facilitate this, two additional mg of midazolam were administered.
Discussion
Spinal Anesthesia
Spinal anesthesia is the injection of medications into the subarachnoid space, which
contains cerebrospinal fluid, with the purpose of blunting or abolishing sensory and/or motor
nerve transmission (Nagelhout & Plaus, 2014). It’s advantages over general anesthesia include
less nausea and vomiting, less urinary retention, reduced opioid requirement, greater mental
awareness, less intraoperative blood loss, decreased incidence of thrombotic events, and less risk
of developing a post-op ileus. Additionally, patients have improved respiratory and cardiac
stability, and are quicker to drink, eat, and ambulate post-operatively (Nagelhout & Plaus, 2014).
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Indicated procedures for the use of spinal anesthesia include those involving the lower
extremities, perineum, and abdomen. It is especially useful for ambulatory procedures as many
complications of general anesthesia are avoided, greatly decreasing the possibility for unforeseen
overnight hospital stays. Spinal anesthesia is very useful in obstetric procedures as it provides
adequate pain control while still allowing baby and mother interaction post-delivery.
Additionally, patients undergoing urologic procedures, such as TURP, can benefit from a spinal
anesthetic as they can alert the urologist of feelings of bladder overdistention, thus reducing the
risk of rupture. Maintaining alertness in these patients also has benefit in that it allows the
anesthetist to detect changes in mental status which is often the first sign of TURP syndrome
(Nagelhout, 2014).
There are some contraindications to spinal anesthesia. Absolute contraindications include
patient refusal, infection at the injection site, symptomatic hypovolemia, coagulopathy,
indeterminate neurological disease, and increased intracranial pressure (NYSORA, 2017).
Patients with a fixed volume cardiac state (such as hypertrophic cardiomyopathy or severe atrial
stenosis) or with severe aortic stenosis (valve area < 1.0 cm2) will not tolerate bradycardia and
hypotension as it will lead to coronary hypoperfusion (Nagelhout, 2014). Relative
contraindications are infection elsewhere, not at the injection site, unknown duration of surgery,
sepsis, uncooperative patient, preexisting neurological deficits, demyelinating lesions, and spinal
deformity (Butterworth, Mackey, & Wasnick, 2013).
There are side effects to spinal anesthesia as well. The severity of these are often
dependent on the level of the block. Cardiovascular side effects can include hypotension, and
bradycardia. Vasomotor tone is influenced by autonomic efferent fibers arising from T5 – L1
spinal levels. Cardiac accelerator nerve fibers exist at spinal levels T1-T4. Pulmonary side
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effects are rare, but the phrenic nerve can be impacted if the block rises to cervical nerves 3 – 5,
causing decreased diaphragm function (Butterworth, Mackey, & Wasnick 2013). Nausea and
vomiting can occur in up to 20% of patients who receive neuraxial anesthesia. This is primarily a
result of hypotension and decreased perfusion to the medulla of the brain, but can also be a result
of increased GI peristalsis due to dominance of parasympathetic input. Finally, with spinal
anesthesia, there is risk of dural puncture and CSF leak, resulting in what is referred to as a
postdural puncture headache. This occurs as the brain loses its “cushion” which is provided by
circulating CSF. The risk of this side effect can be minimized by using smaller gauge, pencil
point needles (Nagelhout & Plaus, 2014).
Mechanism of Spinal Anesthesia-Induced Hypotension
When local anesthetic agents are introduced into the subarachnoid space, the drug
spreads from the injection site and its concentration gradient decreases as it moves further from
this area. A differential blockade results as only the most “local anesthetic susceptible” neurons
will be blocked in the areas of this decreased concentration gradient. Type B autonomic nerve
fibers (sympathetic fibers) are of the most susceptible neurons as they are relatively small in
diameter and lightly myelinated. Because of this, sympathetic neurons tend to be blocked up to
six spinal segments above somatic sensory fibers, which are generally larger in diameter and
more heavily myelinated (Nagelhout & Plaus, 2014).
Nagelhout & Plaus (2014) describe the cardiovascular effects of spinal anesthesia,
“Blockade of the sympathetic nervous system causes arterial vasodilation, decreased systemic
vascular resistance, venous pooling, and reduction in venous return. These changes cause a
redistribution of blood that often results in hypotension” (p. 1083). If the block reaches the
cardiac accelerator fibers, at levels T1 to T4, this hypotension can be amplified by the
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development of bradycardia and decreased cardiac output. In addition to the decreased
sympathetic outflow, the cardiovascular response to spinal anesthesia is affected by baroreceptor
reflexes, volume receptor reflexes, and the Bezold-Jarisch reflex (Nagelhout & Plaus, 2014).
The Bezold-Jarisch reflex (BJR) “is a cardioinhibitory reflex producing bradycardia,
hypotension, and cardiovascular collapse via nonmyelinated, type C fibers whose terminals lie in
the chambers of the heart” (Tubog, Kane, & Pugh, 2017). Trebelsi et al. (2017) indicate that 5hydroxytriptymine subtype 3 (5-HT3) receptors located peripherally may aid in inducing the
BJR. Terkawi et al., 2015 further explain this, “This reflex is mediated by serotonin receptors (5HT3 subtype) located on the vagus nerve and within the wall of cardiac ventricles. They are
activated by serotonin release in response to systemic hypotension and cause an increase in
efferent vagal signaling” (p.344).
Detrimental Effects of Spinal-Induced Hypotension
Perfusion to vital organs depends on adequate blood pressure. Hypotension decreases
perfusion and oxygen delivery which, if severe, will cause ischemia and tissue death. OrtizGomez et al. (2014) outlines the detriments of hypotension in the parturient, including “maternal
nausea and vomiting, and in severe cases unconsciousness, pulmonary aspiration, and placental
hypoperfusion with fetal hypoxia, acidosis, and neurologic injury” (p. 138). Wang et al. (2014)
adds neonatal apnea to this list of hypotension related complications.
In non-obstetric populations, patients may more frequently have comorbidities, such as
hypertension or vascular disease, which might place them at risk for cerebral or myocardial
ischemia related to dramatic decreases in blood pressure. Hines and Marschall (2012) state,
“Chronic hypertension is a cardiovascular, cerebrovascular, and renal risk factor” (p.111-112).
They elaborate by citing intraoperative hypotension as a complicating factor in these patients
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(Hines & Marschall, 2012, p.112). Furthermore, interventions to correct hypotension, such as
volume replacement or administration of ephedrine, might be risky in elderly patients with heart
failure or history of myocardial ischemia (Owczuk et al., 2017). Volume overload can exacerbate
heart failure, and ephedrine can increase myocardia oxygen demand via tachycardia.
Compromised coronary circulation may not have the ability to increase oxygen supply to meet
this demand, which could result in the development of ischemia (Hines & Marschall, 2013, p.1).
Traditional Treatments for SIH
Common preventative and treatment measures for SIH have included positioning, lower
leg compression, loading and co-loading of crystalloids, and administration of alpha and betaadrenergic agonists (Tubog, Kane, & Pugh, 2017). Positioning in trendelenburg can help to
increase venous return, as will lower leg compression, however a large reservoir for volume is in
the splanchnic and GI circulation which leg compression is unable to aid in correcting. Preloading of crystalloids has not proven effective as much of the volume third spaces prior to the
administration of the block. In addition, patients with cardiac or renal deficits, may not tolerate
the volumes used for pre-loading (10-20 ml/kg). Vasopressors are reactive treatments to
hypotension that develops from subarachnoid anesthesia, and while effective, may possess some
negative effects. Pure alpha-adrenergic agonists, such as phenylephrine, might exacerbate
bradycardia that may be brought on by the SAB, and though mixed alpha- and beta-adrenergic
agonists (ephedrine) can be effective, some patients may not tolerate the increase in HR that
accompanies their administration (Butterworth, Mackey, & Wasnick, 2013). Other limitations to
ephedrine can include a relatively slow onset of action and the development of tachyphylaxis
(Lee, George, & Habib, 2016). There is clearly no definitive treatment for SIH, which makes
new options to prevent this side effect appealing to explore.
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Serotonin
Serotonin (5-hydroxytriptymine [5-HT]) is a neurotransmitter which exerts its effects in
many ways throughout the body by binding to a variety of receptors. Principally, in the
cardiovascular system, serotonin induces vasoconstriction (Brunton, Hilal-Dandan, &
Knollmann, 2018). Terkawi et al., (2015) describe this as a result of it binding to 5-HT2
receptors. In the heart, serotonin is both a positive inotrope and positive chronotrope as it binds
to various different 5-HT receptors (Brunton, Hilal-Dandan, & Knollman, 2018). However, when
it binds to 5-HT3 receptors it will activate the BJR causing bradycardia and hypotension
(Terkawi et al, 2015).
The gastrointestinal tract is the primary site of synthesis and storage of serotonin.
Different subtypes of serotonin receptors are responsible for both activation and suppression of
intestinal smooth muscle action, enhancing or suppressing GI motility. Serotonin which acts on
5-HT3 receptors in the GI tract and in the central nervous system induces the emetic response,
causing nausea and vomiting (Brunton, Hilal-Dandan, & Knollman, 2018).
The brain contains all serotonin receptor subtypes. Serotonin is active in the brain in
many ways and influences sleep, cognition, sensory perception, motor activity, temperature
regulation, nociception, mood, appetite, sexual behavior, and hormone secretion. Other various
effects of serotonin include that in the inflammatory response as it is pro-inflammatory via 5HT2 receptors and may play a role in airway inflammation in diseases such as asthma.
Additionally, serotonin is released from platelets to cause a local vasoconstrictor response,
promoting hemostasis after vessel damage (Brunton, Hilal-Dandan, & Knollman, 2018).
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Ondansetron
Ondansetron is a serotonin receptor subtype 3 (5-HT3) antagonist. It is commonly used as
an antiemetic, working to block 5-HT3 receptors in the GI system and in the chemoreceptor
trigger zone of the brain. It has a rapid onset and its duration of action is about 6-12 hours (Vargo
Anesthesia, 2012). Aside from its central action in the brain, ondansetron will bind to 5-HT3
receptors peripherally, including those within the cardiac ventricles and on the vagus nerve,
which help to mediate the BJR (Trebelsi et al., 2017). Binding these receptors prevents induction
of the BJR and decreases parasympathetic dominance, lessening the degree of bradycardia and
hypotension brought about by spinal anesthesia.
Adverse Effects
The most common adverse effects of ondansetron (and other 5-HT3 antagonists) include
diarrhea, fever, and headache (Butterworth, Mackey, & Wasnick, 2013). Wang et al. (2014), also
cite constipation and asthenia as potential side effects. There have also been reports of
prolongation of the QT interval with these agents (more frequently with Dolasetron), however,
this effect has not been linked clinically to any adverse arrhythmias. It may also be important to
note that ondansetron is metabolized by the CYP-450 enzymes of the liver, necessitating
consideration in its dosing for patients in liver failure (Butterworth, Mackey, & Wasnick, 2013).
Finally, in previous years, there has been concern that prenatal exposure to ondansetron can
cause adverse outcomes of pregnancy including spontaneous abortion, still birth, major birth
defects, preterm delivery, and low birth weight infants. Wang et al. (2014), explain that
appropriate exposure to ondansetron does not cause these adverse effects. “Ondansetron
administration during the first trimester of pregnancy is not associated with an increased risk for
major malformations above baseline” (Wang et al, 2014, p.5214).
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Ondansetron Administered Prior to SAB
A total of 13 randomized controlled trials, which explored the effects of intravenous
ondansetron administered prior to the establishment of spinal anesthesia, were reviewed.
Methods of each trial are similar although there is some variability.
Obstetric Populations
Trabelsi et al. (2015) examined the effect ondansetron has on maternal hypotension and
on certain neonatal parameters, including APGAR score, umbilical artery pH, and neonatal
lactate levels. They included 80 patients undergoing cesarean section split into two groups, a
control group and an intervention group which received 4 mg ondansetron five minutes prior to
SAB. Saline (10 ml/kg) was given as a bolus as well. The spinals included 2 ml bupivacaine
0.5% (10 mg) and 10 mcg sufentanil. Hypotension was defined as a drop in BP > 20% from
baseline, or MAP < 80 mmHg. They determined that a statistically significant difference existed
in the incidence of hypotension (77.5% in the control group, 37.5% in the group which received
ondansetron) between groups. They also note that more ephedrine was required in the control
group. Of the neonatal parameters, they found higher APGAR scores, lower lactate levels, and
higher cord arterial pH in the intervention group (p. 1-7).
Wang et al. (2014) looked at different doses of ondansetron compared to a control group
and how it affected hemodynamics in parturient patients undergoing cesarean section. They also
looked at neonatal outcomes. One hundred and fifty primiparous patients were split into five
equal groups; a control group, and four intervention groups each of which received either 2, 4, 6,
or 8 mg of ondansetron 5 minutes prior to establishment of the SAB. All patients were injected
with 10 mg bupivacaine intrathecally. After the spinal was performed, LR solution was given
rapidly up to 10 ml/kg. After delivery, 10 units oxytocin in 250 ml saline was given at an
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unspecified rate. Hypotension was defined as a drop in baseline SBP by 20% or greater. The
incidence of hypotension was found to be less in the groups who received ondansetron in 4 mg
and 6 mg doses, and these differences were found to be statistically significant. Regarding
neonatal outcomes, no significant differences were noted in APGAR scores, birth weight, nor
umbilical cord arterial pH between groups. The pH of umbilical cord venous blood, however,
was significantly higher in the group which received four mg ondansetron (p. 5210-5216).
Terkawi et al. (2015) had differing results in their study which evaluated ondansetron’s
effect on hemodynamics in patients undergoing cesarean section. Eighty-six patients were split
into two groups, a control group and an intervention group which received 8 mg ondansetron five
minutes prior to SAB. All patients were preloaded with 500 ml Hetastarch, and plasmalyte was
used as maintenance fluid. The spinal was established using 2 mL of 0.75% bupivacaine (15
mg), with 20 mcg fentanyl, and 100 mcg morphine. Hypotension was defined as SBP < 90
mmHg. They determined there was no significant difference in the development of hypotension
between the two groups. They also did not find a difference in amount of vasopressor used to
correct hypotension (p. 344-348).
Khouly & Meligy (2016) looked at 102 parturients undergoing cesarean section. A
control group which received saline was compared to the intervention group which received 4
mg ondansetron five minutes prior to SAB. Two mL of 0.5% bupivacaine (10 mg) was
administered intrathecally to each patient. After the spinals were administered, patients were
placed supine with a left tilt. Hypotension was defined as SBP < 75% baseline value, SBP below
90 mmHg, or DBP < 60 mmHg. The authors determined that SBP, MAP, and HR values were
increased in the intervention group compared to the control group. Additionally, less
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vasopressors were required in the intervention group; ephedrine was administered to 58% of
patients in the control group versus 30% of patients in the intervention group (p. 205-209).
Sahoo, SenDasgupta, Goswami, & Harza (2012) looked at parturient patients undergoing
cesarean section as well, using a control group (n = 26) and an intervention group (n = 26) which
received 4 mg ondansetron prior to the SAB. All patients were pre-loaded with lactated ringers
20 ml/kg/h over 30 minutes. The spinal was established using 2 mL 0.5% bupivacaine (10 mg)
and a left tilt was applied post-block. Hypotension was defined as SBP < 90 mmHg or DBP < 60
mmHg. Significant MAP decreases were observed in both groups. In the intervention group, the
lowest average mean arterial pressure was 82 mmHg compared to 74 mmHg in the control
group. Additionally, 42% of control group patients required phenylephrine administration versus
7.6% of intervention group patients. (p. 24-28).
Ortiz-Gomez et al. (2014) examined 128 parturients who underwent cesarean section.
The subjects were divided into four equal groups; a control group, and three study groups which
received different doses of ondansetron (2 mg, 4 mg, & 8 mg) prior to SAB. The dose of
hyperbaric bupivacaine 0.5% was administered based on height (height in cm X 0.06), and 20
mcg fentanyl was added to each. The authors found no significant difference in the incidence of
hypotension. They did, however, find that the study groups which received 4 mg and 8 mg of
ondansetron required about half as much ephedrine to correct hypotension (p. 138-143).
Marciniak et al. (2015) studied 72 patients undergoing cesarean section. The study cohort
was split into two groups, a control group and an intervention group in which each patient
received 8 mg ondansetron five minutes before administration of the spinal. Each patient was
preloaded with Hetastarch 10 ml/kg. Bupivacaine 0.5% was administered according to height
(1.8-2.2 ml; 9-11mg). Fentanyl 15 mcg was added to each spinal preparation. Post-block, every
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patient was positioned supine with a left tilt. Hypotension was defined as a 20% decrease in SBP
or SBP < 90 mmHg. The authors determined that were no significant differences in
hemodynamic parameters between each group (p. 461-467).
Karacaer et al. (2017) examined prophylactic intravenous ondansetron and its effect on
norepinephrine consumption in patients undergoing cesarean section. A total of 108 patients
were split evenly into a control group and an intervention group, which received 8 mg
ondansetron intravenously prior to receiving the spinal. Co-loading with LR was done, and each
patient was administered 10 mg bupivacaine, and 20 mcg fentanyl intrathecally. After the spinal
administration, all patients were placed supine with a left tilt. Hypotension was defined as SBP <
80% of the patient’s baseline value. The authors determined that incidence of hypotension was
statistically equal between groups (88% versus 87%), however, norepinephrine consumption was
greater in the control group. In this group, 35.7 +/- 25.8 mcg of norepinephrine was required,
versus the intervention group where 22.6 +/- 19.5 mcg of norepinephrine was used (90-97).
A study by Nivatpumin & Thamvittayakul (2016) compared the effectiveness of
ondansetron and ephedrine using the respective intervention groups (ondansetron 8 mg,
ephedrine 10 mg), as well as a control group. One hundred and sixty-eight patients were
enrolled. Each patient was pre-loaded with 500 ml LR, and a spinal was delivered with 11 mg
bupivacaine and 200 mcg morphine. The study medications (ephedrine or ondansetron) were
given after administration of the spinal. Each patient was also placed supine with left tilt at this
time. Hypotension was defined as SBP < 90 or SBP decrease of 20% or greater. The authors
determined that “the proportions requiring ephedrine and/or norepinephrine after spinal
anesthesia in group [ephedrine] and [ondansetron] were not significantly different” (p. 27) and
that the incidence of hypotension was not significantly different between groups (25-31).
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Wang et al. (2014) looked at the effectiveness of ondansetron preloading coupled with
crystalloid infusion to reduce maternal hypotension after spinal anesthesia for cesarean sections.
A control group was compared with an intervention group which received 4 mg ondansetron
prior to the delivery of the spinal anesthetic. All patients were given 2 mL of 0.5% (10 mg)
bupivacaine and were bolused with 10 mL/kg Lactated Ringer’s solution. Hypotension was
defined as SBP < 80% baseline and was treated with phenylephrine. The study showed a mean
maximal decline in SBP of 18.9 +/- 6.3 mmHg in the group which received ondansetron and 30.7
+/- 16.6 mmHg in the control group. This was determined to be statistically significant.
Phenylephrine administration was also significantly different with the intervention group
receiving a total of 1,300 mcg and the control group receiving 3,100 mcg in total (p. 913-922).
Non-Obstetric Populations
Marashi, Soltani-Omid, Mohammadi, Aghajani, & Movafegh (2014) completed a study
that compared administration of ondansetron in two doses (6 mg and 12 mg) to a placebo dose of
saline. Two hundred and ten patients in varying procedures (urologic, orthopedic, and
gynecological) were divided into three groups; a control group which received saline, a group
which received ondansetron 6 mg, and a group which received ondansetron 12 mg prior to
administering the SAB. Hyperbaric 0.5% bupivacaine 15 mg was used for the block. They
defined hypotension as a MAP < 80 mmHg and their findings illustrate that only patients in the
control group (17%) developed hypotension. This was determined to be of statistical
significance. The authors did not indicate how each patient population was distributed to each
study group (p.1-5).
Owczuk et al. (2008) compared 35 patients in a control group to 36 patients who received
8 mg ondansetron prior to SAB. No specific population of patients was identified, only that they
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all received spinal anesthesia. No preloading of fluids was done prior to the procedure. In fact,
each patient was limited to 200 ml sodium chloride during the study period. Each patient
received oral midazolam (7.5 mg) one hour prior to anesthesia. Four ml bupivacaine 0.5% (20
mg) was administered intrathecally to each patient. Hypotension was defined as SBP < 90
mmHg. They determined a significant difference between groups in development of
hypotension; 20% of patients in the control group versus 2.7% of patients in the intervention
group developed hypotension (p.332-339).
Owczuk et al. (2015) examined 53 patients all greater than 70 years of age. The control
group had 27 patients and was compared to 26 patients in an intervention group which received 8
mg ondansetron five minutes before SAB. Fluids were limited to 200 ml or less during the study
period. Each patient was given 2.5 to 3 ml 0.5% bupivacaine (12.5 – 15 mg) intrathecally.
Hypotension was defined as SBP < 90 mmHg, or a SBP decrease of > 20% baseline value. The
authors determined that in the intervention group, SBP was significantly higher five minutes
after the block was established, and that MAP and DBP were significantly higher at post-block
intervals of 5, 10, and 15 minutes (p.598-607).
Article Review Discussion
There have been many studies looking at how intravenous ondansetron affects
hemodynamics after the administration of spinal anesthesia. Unfortunately, there exists a large
variation in how these studies were conducted. Perhaps the most noteworthy differences include
amount and dose of local anesthetic used, adjunct medications used in the spinals, the use of
colloid or crystalloid pre- or co-loading, definitions of hypotension, the threshold for treating
blood pressure, patient populations and demographics, and dose of ondansetron used.
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Of the 13 studies reviewed, eight determined that pre-treating with intravenous
ondansetron did reduce the incidence of resultant hypotension. Five of the studies determined
that the incidence of hypotension was the same between treatment and control groups. While not
all the studies addressed the amount of vasopressor medications used, seven cited that patients
who were pretreated with ondansetron required less. Only one cited that the vasopressor load
was the same between study groups.
An additional barrier in determining the true effectiveness of this intervention, is that
there are many factors that could contribute to the development of hypotension (not exclusively
sympathectomy from spinal anesthesia). Some of these factors include, but are not limited to, the
administration of Pitocin, which can cause transient hypotension if rapidly infused, the use of
propofol infusions, which inhibits sympathetic vasoconstrictor activity, and metabolic
byproducts that may accumulate if a tourniquet is used (Butterworth, Mackey, & Wasnick,
2013).
Practice Recommendations
There remains a need for additional, more uniform studies on this topic. Though likely it
will be impossible to abolish all variations that exist between the studies, if some of the variables
are eliminated, a more determinant conclusion could be reached on the effectiveness of this
intervention. Until then, it does seem prudent to administer 4 mg ondansetron intravenously
about five minutes prior to administering spinal anesthesia. The reasons for this conclusion
include a lack of risk and adverse effects of this dose, the potential for decreasing hypotension,
which does have negative consequences, and the likelihood of using a decreased amount of
vasopressor medication, which is cost saving. Most of these patients will receive ondansetron
during the procedure anyway, so there is no additional cost of this practice. It is important,
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however, that each anesthesia practitioner uses case-to-case judgement. It should be realized that
this practice cannot fully replace the current strategies of mitigating spinal-induced hypotension,
but should rather be looked at as an additional strategy to be used in conjunction with the tools
that already exist (fluid loading, positioning, etc.).
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